SEC
TWST icon

Seven Eight Capital’s Twist Bioscience TWST Stock Holding History

Seven Eight Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-38,420
Closed -$1.42M – 827
2023
Q4 		$1.42M Buy
38,420
+23,305
+154% +$539K 0.16% 189
2023
Q3 		$306K Buy
+15,115
New +$332K 0.04% 488
2023
Q2 		– Sell
-76,726
Closed -$1.16M – 655
2023
Q1 		$1.16M Buy
+76,726
New +$1.69M 0.24% 109
2022
Q4 		– Sell
-11,549
Closed -$407K – 639
2022
Q3 		$407K Buy
+11,549
New +$490K 0.08% 320
2021
Q4 		– Sell
-4,619
Closed -$494K – 679
2021
Q3 		$494K Sell
4,619
-4,100
-47% -$469K 0.05% 437
2021
Q2 		$1.16M Buy
+8,719
New +$1.01M 0.16% 217

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Seven Eight Capital's TWST Position: Q1 2024 in Review

Seven Eight Capital sold out of Twist Bioscience (TWST) in Q1 2024, closing a stake of 38,420 shares — an estimated $1.42M sold.

Seven Eight Capital first reported a position in TWST in Q2 2021 and held it in 6 quarters. The position peaked at $1.42M in Q4 2023. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

  • Seven Eight Capital reported no remaining Twist Bioscience position as of Q1 2024 after selling out during the quarter.
  • Seven Eight Capital sold 38,420 Twist Bioscience shares in Q1 2024, an estimated $1.42M.
  • Seven Eight Capital first reported a position in Twist Bioscience in Q2 2021 and held it in 6 quarters.
  • Seven Eight Capital's Twist Bioscience position peaked at $1.42M in Q4 2023.
  • 237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Seven Eight Capital's 13F filing for Q1 2024, filed 13 May 2024.